Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 101 - 125 of 13777 in total
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to...
Approved
Investigational
Matched Synonyms: … 4'-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid ... 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid ... 4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid …
Matched Iupac: … 4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl ... ]-2-carboxylic acid …
Matched Description: … Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. ... the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial ... telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of
Matched Categories: … Angiotensin 2 Receptor Blocker ... Heterocyclic Compounds, 2-Ring ... Angiotensin II Type 2 Receptor Blockers …
Technetium Tc-99m sestamibi (commonly sestamibi) is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile (MIBI) ligands, hence the name sesta (6) MIBI.. Following intravenous injection of the drug, Technetium Tc-99m sestamibi is taken up by...
Approved
Investigational
Matched Iupac: … technetium(1+) ion hexakis(1-isocyano-2-methoxy-2-methylpropane) …
Matched Description: … (MIBI) ligands, hence the name sesta (6) MIBI.. ... by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects); and 2) ... Technetium Tc-99m sestamibi (commonly sestamibi) is a pharmaceutical agent used in nuclear medicine imaging …
Matched Categories: … Diagnostic Uses of Chemicals ... Compounds used in a research, industrial, or household setting …
Matched Products: … Kit for the Preparation of Technetium Tc99m Sestamibi …
Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb, each of which contributes one heavy chain and one light chain to drug structure. The resulting 4-chain bispecific...
Approved
Investigational
Matched Synonyms: … -CHAIN, (223->217')(2 ... B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB ... -CHAIN) (HUMAN-MUS MUSCULUS MONOCLONAL PF-06863059 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS …
Matched Description: … It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs ... [L47815] On August 14, 2023, the FDA granted accelerated approval to elranatamab for the treatment of ... ), an anti-BCMA mAb and an anti-CD3 mAb,[A261060] each of which contributes one heavy chain and one light …
Deflazacort, also known as Emflaza, is a corticosteroid prodrug used as an agent to manage Duchenne Muscular Dystrophy (DMD). It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.[L6694,FDA label] Duchenne Muscular Dystrophy is an inherited disorder resulting from mutations of the dystrophin gene, which...
Approved
Investigational
Matched Iupac: … ]icosa-6,14,17-trien-8-yl]-2-oxoethyl acetate ... 2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸ …
Matched Description: … the dystrophin gene, which is important for muscle function. ... It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA. ... [A179446,A179449,L6697] This disease usually manifests by muscle weakness in early childhood followed …
Matched Products: … CALCORT 6 ... CLOBAK 6 MG ... DEFLAZACORT 6 MG …
Approved
Experimental
Matched Iupac: … 2-(2-{2-[2-(benzoylsulfanyl)acetamido]acetamido}acetamido)acetic acid …
Matched Products: … Kit for the Preparation of Technetium Tc99m Mertiatide …
A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
Approved
Investigational
Vet approved
Matched Synonyms: … 6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin ... 2-Sulfanilamido-4,6-dimethylpyrimidine ... 4,6-Dimethyl-2-sulfanilamidopyrimidine …
Matched Iupac: … 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzene-1-sulfonamide …
Matched Description: … It has a spectrum of antimicrobial action similar to other sulfonamides. …
Matched Categories: … combinations of sulfonamides …
A histamine congener, it competitively inhibits histamine binding to histamine H2 receptors. Cimetidine has a range of pharmacological actions. It inhibits gastric acid secretion, as well as pepsin and gastrins output. It also blocks the activity of cytochrome P-450 which might explain proposals for use in neoadjuvant therapy.
Approved
Investigational
Matched Synonyms: … 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine ... 2-cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)guanidine ... N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]thio}ethyl)guanidine …
Matched Iupac: … (Z)-N''-cyano-N-methyl-N'-(2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl)guanidine …
Matched Description: … It also blocks the activity of cytochrome P-450 which might explain proposals for use in neoadjuvant ... Cimetidine has a range of pharmacological actions. …
Matched Salts cas: … 70059-30-2
Matched Mixtures name: … Cimetidine 5% / Ibuprofen 2% / Salicylic Acid 17% …
Matched Categories: … MATE 2 Inhibitors ... MATE 2 Substrates ... Metabolic Side Effects of Drugs and Substances …
Matched Products: … Cimetidine in Sodium Chloride …
Erenumab (AMG-334) (INN; trade name Aimovig) is a human monoclonal antibody designed specifically to bind and antagonize the calcitonin gene-related peptide receptor (CGRPR) as a means to prevent migraines. Aimovig, as released and marketed by Novartis and Amgen, is in fact a novel therapeutic approach as the first and only...
Approved
Investigational
Matched Description: … It is composed of 2 heavy chains, each containing 456 amino acids, and 2 light chains of the lambda subclass ... Aimovig) is a human monoclonal antibody designed specifically to bind and antagonize the calcitonin gene-related ... , each containing 216 amino acids, with an approximate molecular weight of 150 kDa [FDA Label]. …
Matched Categories: … Calcitonin Gene-Related Peptide (CGRP) Antagonists ... Calcitonin Gene-Related Peptide Receptor Antagonists …
Matched Products: … AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN 70MG/ML ... AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED PEN 140MG/ML ... AIMOVIG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 70MG/ML …
Galcanezumab is a humanized monoclonal antibody developed by Eli Lilly and Company against human calcitonin gene-related peptide (CGRP). Although several small-molecule CGRP receptor antagonists have been developed, humanized monoclonal antibodies like galcanezumab are specifically designed to selectively bind to CGRP entities with high potency. Given this target specificity, lack of...
Approved
Investigational
Matched Description: … A pregnancy exposure registry has been established to evaluate the safety of this drug in pregnant women ... Galcanezumab is a humanized monoclonal antibody developed by Eli Lilly and Company against human calcitonin gene-related ... treatment of migraine and the treatment of episodic cluster headache. …
Matched Categories: … Calcitonin Gene-Related Peptide (CGRP) Antagonists ... Calcitonin Gene-Related Peptide Receptor Antagonists …
Matched Products: … EMGALİTY 120 MG/ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM, 2 ADET ... EMGALITY SOLUTION FOR INJECTION IN PRE-FILLED PEN 120 MG/ML ... Pontevia 120 mg solution for injection in pre-filled pen …
Milk thistle is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Approved
Experimental
Investigational
Matched Synonyms: … Fruit of Silybum Marianum …
Matched Description: … Milk thistle is a plant/plant extract used in some OTC (over-the-counter) products. …
Busulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It is not a structural analog of the nitrogen mustards. It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), but although symptomatic relief is provided, no permanent remission is brought...
Approved
Investigational
Matched Description: … It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), ... It is not a structural analog of the nitrogen mustards. …
Matched Products: … MYRAN TABLETS 2 mg ... MYLERAN TABLETAS 2 MG ... Myleran 2 mg Filmtabletten …
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it...
Approved
Investigational
Vet approved
Matched Iupac: … (1R,2R,4S,5S,7R)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0 …
Matched Description: … It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic ... treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in ... It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works …
Matched Products: … SKOPOLIN AMPUL, 6 ADET ... SPAZMOTEK SUPOZITUAR, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ İÇEREN AMPUL, 6 AMPUL …
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Approved
Investigational
Matched Iupac: … (2R)-2-amino-3-{[(2S)-2-{[(1R)-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido ... carbamoylbutyl]carbamoyl}ethyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}butyl]carbamoyl}ethyl]carbamoyl}-2- …
Matched Description: … Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing ... HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017. ... Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism ( …
Matched Salts cas: … 1334237-71-6
Matched Products: … PARSABİV 10 MG/2 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Valerian is extracted from a herb that is a perennial flowering plant. Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is not completely understood. Valerian has been used in the treatment of conditions including sleep disorders, anxiety, attention deficit-hyperactivity disorder (ADHD) and joint...
Approved
Experimental
Investigational
Matched Description: … Valerian has been used in the treatment of conditions including sleep disorders, anxiety, attention deficit-hyperactivity ... [DB00313] is a derivative of valeric acid, which is obtained from the plant root. ... Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is …
Matched Products: … Tincture Of Valerian …
Iodine is commonly used as an antiseptic for minor cuts and abrasions, preventing infections that may result from contaminated wounds. Additionally, iodine has been studied in the treatment of fibrocystic disease and breast cancer.[A3413,A192153,A192156,A192159]
Approved
Investigational
Matched Description: … Additionally, iodine has been studied in the treatment of fibrocystic disease and breast cancer. …
Matched Mixtures name: … Sclerodine 6 Injection ... For-2 ... Tincture Of Iodine …
Matched Products: … Tincture Of Iodine 5% …
Nonoxynol-9 (N-9) is a typical surfactant used as a vaginal spermicide. Spermicides are locally acting non-hormonal contraceptives. When present in the vagina during intercourse, they immobilize/inactivate/damage and/or kill sperms without eliciting systemic effects. N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams,...
Approved
Withdrawn
Matched Description: … N-9 has been in use for more than 30 years as an over-the-counter (OTC) drug in creams, gels, foams and ... In several European countries, spermicides are no longer on the market. ... It is the most commonly used spermicidal contraceptive in the UK and the USA. …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors, VEGFR1 and VEGFR2, fused with the Fc region of human immunoglobulin gamma 1 (IgG1). Structurally, Aflibercept is a dimeric glycoprotein with a protein molecular weight of 96.9 kilo Daltons (kDa). It...
Approved
Matched Description: … retinopathy of prematurity in preterm infants in February 2023 and for the treatment of wet age-related ... [A261281,A261286] Due to the 2 fused VEGFR, aflibercept has a higher affinity to the cognate ligands ... [L47976] An aflibercept biosimilar, Yesafili, was approved for use in the EU in September 2023. …
Matched Products: … EYLEA 40MG/ML SOLUTION FOR INJECTION IN VIAL ... EYLEA SOLUTION FOR INJECTION IN VIAL 2MG ... EYLEA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 2MG …
Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1.[L14862,A216522] The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1....
Approved
Investigational
Matched Description: … Etanercept is produced by recombinant DNA technology in a Chinese hamster ovary (CHO) mammalian cell ... Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton ... It consists of 934 amino acids. …
Matched Products: … COZ.ICIN KULLANIMA HAZIR KALEM, 2 ADET ... BENEPALI 50MG IN FER ... BENEPALI 25MG ILO IN FER …
Mobocertinib is a kinase inhibitor targeted against human epidermal growth factor receptor (EGFR). It is used specifically in the treatment of non-small cell lung cancer (NSCLC) caused by exon 20 insertion mutations in the EGFR gene, which are typically associated with a poorer prognosis (as compared to "classical" EGFR mutants...
Approved
Investigational
Matched Iupac: … propan-2-yl 2-[(4-{[2-(dimethylamino)ethyl](methyl)amino}-2-methoxy-5-(prop-2-enamido)phenyl)amino]-4 …
Matched Description: … It is used specifically in the treatment of non-small cell lung cancer (NSCLC) caused by exon 20 insertion ... September 2021 for the treatment of locally advanced or metastatic NSCLC in patients with _EGFR_ exon ... mutations in the _EGFR_ gene,[L38368] which are typically associated with a poorer prognosis (as compared …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Insulin glulisine is a short-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the...
Approved
Matched Description: … Insulin is also used in the treatment of Type 2 Diabetes (T2D), another form of diabetes mellitus that ... Type 1 and Type 2 Diabetes. ... high levels of insulin in a short period of time to mimic the release of endogenous insulin from the …
Matched Categories: … Drugs Used in Diabetes …
Matched Products: … APIDRA 100 U/ML- SOLUTION FOR INJECTION IN VIAL ... APIDRA 100 Units/ml Solution for Injection in vial ... APIDRA SOLOSTAR 100 UNITS/ML, SOLUTION FOR INJECTION IN A PRE-FILLED PEN …
Inositol is a collection of nine different stereoisomers but the name is usually used to describe only the most common type of inositol, myo-inositol. Myo-inositol is the cis-1,2,3,5-trans-4,6-cyclohexanehexol and it is prepared from an aqueous extract of corn kernels by precipitation and hydrolysis of crude phytate. These molecules have structural...
Approved
Investigational
Withdrawn
Matched Description: … [L1113] By the FDA, inositol is considered in the list of specific substances affirmed as generally recognized ... the body, a deficiency in this molecule does not translate into disease conditions. ... the most common type of inositol, myo-inositol. …
Matched Mixtures name: … Harvest Of Values All B Complex Tab ... For-2 ... Stom #2
Evolocumab is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. It is a subcutaneous injection approved by the FDA for individuals on maximum statin therapy who still require additional LDL-cholesterol lowering. It is approved for both homozygous and heterozygous familial cholesterolemia as an adjunct to other first-line...
Approved
Matched Description: … designed to bind to PCSK9 and inhibit PCSK9 from binding to LDL receptors on the liver surface, resulting in ... Evolocumab is a monoclonal antibody designed for the treatment of hyperlipidemia by Amgen. ... more LDL receptors on the surface of the liver to remove LDL-C from the blood. …
Matched Products: … REPATHA 140 MG/ML SC ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM, 2 ADET ... REPATHA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 140MG/ML ... Repatha Solution for Injection in Pre-filled Syringe 140mg/mL (evolocumab) …
Golodirsen is a morpholino antisense oligomer designed to treat about 8% of patients with Duchenne Muscular Dystrophy (DMD). This is an X-linked condition leading to progressive muscle degeneration that begins in early childhood, rendering many patients wheelchair-bound by age 12. Often, patients succumb to this condition by age 30 or...
Approved
Matched Description: … [A188580,T756] A similar drug used in the treatment of other types of DMD is [eteplirsen], which targets ... This is an X-linked condition leading to progressive muscle degeneration that begins in early childhood ... Continued approval of this drug will depend on the results of clinical trials that confirm its clinical …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Tolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory agent. It was discovered by scientists at Medica Pharmaceutical Company in Finland. It is used in the UK as a treatment for migraine under the name of Clotam. In the US, it presents a Status class I by the...
Approved
Investigational
Matched Iupac: … 2-[(3-chloro-2-methylphenyl)amino]benzoic acid …
Matched Description: … By the European Medicine Agency, it was granted in 2016 with the status of orphan for the treatment of ... It is used in the UK as a treatment for migraine under the name of Clotam. ... Tolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory …
Matched Categories: … Non COX-2 selective NSAIDS …
Matched Products: … TOLFEDINE TABLETS 6 MG …
Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor.[A39984,A39999] It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA. This drug is frequently known as Humira. It is produced...
Approved
Experimental
Matched Description: … Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid ... [L49101] A biosimilar marketed as Hyrimoz, a high-concentration formulation of adalimumab, is also available ... [A39984,A39999] It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA. …
Matched Products: … HYRİMOZ 40 MG/0,8 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM, 2 ADET ... HUMİRA 20 MG/0,2 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADET ... AMGEVİTA 40 MG/0.8 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM (2 ADET) …
Displaying drugs 101 - 125 of 13777 in total